[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
The aim of this study was to establish and optimize the imaging method of \[68Ga\]Ga-NOTA-RW102, as well as its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agent was evaluated in patients with non-small cell lung cancer
• Patients with PD-L1-positive non-small cell lung cancer
‣ Age between 18 and 65 years old, gender is not limited.
⁃ Patients with CT findings that can be occupied on the lung with a diameter greater than 1cm or more who have not undergone surgery.
⁃ Lung cancer patients with a clinical diagnosis of positive PD-L1 expression;
⁃ Written informed consent must be signed by the subject or his/her legal guardian or caregiver.
⁃ Willingness and ability to cooperate with all programs of this study.